Interaction Guide · Research summary

Can I take Arctostaphylos Uva-Ursi with Chlorothiazide?

Review Arctostaphylos Uva-Ursi with Chlorothiazide: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

It is not established that bearberry adds to chlorothiazide-related low blood pressure. The main practical issue is reviewing the exact leaf product and kidney history, without assuming traditional urinary use proves an interaction.

What this answer covers

Arctostaphylos uva-ursi species entry; regulatory evidence concerns specified oral leaf preparations.

Supplement or preparation
Arctostaphylos uva-ursi
Medication ingredient
chlorothiazide

What is known about the combination

The bearberry leaf monograph reports no interactions, and the reviewed sources do not demonstrate extra hypotension with chlorothiazide. A lack of reports is not proof that every preparation is safe.

Why kidney history matters

The monograph contraindicates these leaf products in women with kidney disorders. Chlorothiazide can worsen kidney function if too much fluid is lost. These separate precautions support a product review but do not establish additive blood-pressure lowering.

The plant part matters

The monograph concerns leaf preparations for short-term lower urinary symptoms. It does not evaluate all extracts, other plant parts or multi-herb blends. The actual ingredients and preparation should be checked rather than relying on the word bearberry.

Respond to symptoms

Tell the treating team about new urinary or weight-loss products, dizziness, faintness, marked thirst or reduced fluid intake. Chlorothiazide can itself cause excess fluid loss and kidney problems. Follow your existing fluid plan rather than increasing fluids or changing chlorothiazide on your own.

Evidence and practical considerations

Side effects & toxicity

Available preparation-specific guidance and indirect human studies do not establish this exact-pair adverse outcome; absence of proof is not proof of safety.

Exact scope
Arctostaphylos uva-ursi species entry; regulatory evidence concerns specified oral leaf preparations. with Oral chlorothiazide, exact RxCUI2396 IN. No automatic transfer from loop diuretics or another thiazide.
Medication form and route
oral medication; oral supplement

What remains uncertain

  • No universal risk rate or spacing interval; individual source limitations apply.

Factors that may matter: Preparation and plant part; Dose and duration; Kidney function; Fluid status; Other medicines; Calcium or potassium status.

Research conclusion: insufficient evidence · Evidence assessment: very low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People treated with oral chlorothiazide

Can cause fluid and electrolyte disturbances, including low potassium and sodium. Reduces urinary calcium excretion and can raise serum calcium; substantial elevation needs evaluation.

How this applies: Exact medication, salt, route, plant part, formulation and clinical endpoint govern applicability.

Exact oral product; not another thiazide or loop diuretic. Chlorothiazide sodium intravenous therapy is a separate route and salt. THALITONE has product-specific bioavailability and should not be assumed dose-for-dose identical to other formulations.

Source 2: regulatory guidance

ema.europa.eu · Source check Sep 10, 2026

Population: People using the specified oral preparation.

No interactions reported. The covered leaf products are contraindicated in women with kidney disorders.

How this applies: Interpret only for the stated species, preparation, route and endpoints; exact chlorothiazide pair evidence is distinguished.

Not a chlorothiazide combination or human blood-pressure study; species-level identity does not identify every preparation.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Prepared exact-pair article with separately verified drug label, original human evidence and explicit preparation and endpoint limitations.
Research summary published

Article revision: ece444d4aebd6e60

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.